Supplement for joint pain connected to dementia worsening

A comprehensive analysis has concluded that regular use of the supplement glucosamine, commonly used to treat joint pain, is associated with a 25% increased risk of developing cognitive decline leading to dementia. The analysis also showed that this usage is linked to a 25% increase in the likelihood of death among patients with dementia, with the effect being more pronounced in those already suffering from the condition. The findings suggest that glucosamine may exacerbate harmful processes in the brain, warranting further clinical research on this matter.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل